Millipore Sigma Vibrant Logo

211280 Capsazepine - CAS 138977-28-3 - Calbiochem

View This Product on Sigma-Aldrich
211280
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
138977-28-3C₁₉H₂₁N₂O₂SCl

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
211280-10MGCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 10 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA competitive antagonist of Capsaicin (Cat. No. 211274) and resiniferatoxin. Capsazepine (1 µM) blocks capsaicin (60 nM) stimulated firing of C-fibers.
      Catalogue Number211280
      Brand Family Calbiochem®
      SynonymsN-[2-(4-Chlorophenyl)ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbothioamide
      References
      ReferencesFox, A.J., et al. 1995. Neuroscience 67, 741.
      Ellis, J.L., and Undem, B.J. 1994. J. Pharmacol. Exp. Ther. 268, 85.
      Walpole, C.S.J., et al. 1994. J. Med. Chem. 37, 1942.
      Szallasi, A., et al. 1993. J. Pharmacol. Exp. Therap. 267, 728.
      Product Information
      CAS number138977-28-3
      ATP CompetitiveN
      FormOff-white solid
      Hill FormulaC₁₉H₂₁N₂O₂SCl
      Chemical formulaC₁₉H₂₁N₂O₂SCl
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetA competitive antagonist of Capsaicin and resiniferatoxin
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +15°C to +30°C
      Do not freeze Ok to freeze
      Special InstructionsUnstable in solution; reconstitute just prior to use.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      211280-10MGCN 04055977219180

      Documentation

      Capsazepine - CAS 138977-28-3 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Capsazepine - CAS 138977-28-3 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      211280

      参考資料

      参考資料の概要
      Fox, A.J., et al. 1995. Neuroscience 67, 741.
      Ellis, J.L., and Undem, B.J. 1994. J. Pharmacol. Exp. Ther. 268, 85.
      Walpole, C.S.J., et al. 1994. J. Med. Chem. 37, 1942.
      Szallasi, A., et al. 1993. J. Pharmacol. Exp. Therap. 267, 728.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision16-November 2016 JSW
      SynonymsN-[2-(4-Chlorophenyl)ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbothioamide
      DescriptionA competitive antagonist of the sensory neuron excitants capsaicin (Cat. No. 211274) and resiniferatoxin (Cat. No. 553975). Capsazepine (1 µM) blocks capsaicin (60 nM) stimulated firing of C-fibers.
      FormOff-white solid
      CAS number138977-28-3
      Chemical formulaC₁₉H₂₁N₂O₂SCl
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO or Methanol
      Storage +15°C to +30°C
      Do Not Freeze Ok to freeze
      Special InstructionsUnstable in solution; reconstitute just prior to use.
      Toxicity Standard Handling
      ReferencesFox, A.J., et al. 1995. Neuroscience 67, 741.
      Ellis, J.L., and Undem, B.J. 1994. J. Pharmacol. Exp. Ther. 268, 85.
      Walpole, C.S.J., et al. 1994. J. Med. Chem. 37, 1942.
      Szallasi, A., et al. 1993. J. Pharmacol. Exp. Therap. 267, 728.